SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BSD Medical (Long Term Investment Oriented)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: pleonastic who wrote (40)1/16/2013 9:11:26 PM
From: fwhco1 Recommendation  Read Replies (1) of 178
 
'...The only full-FDA-approval “hold up” for BSD M’s 2000-series of products (the “Big Bertha’s”, so to speak) is with respect to long term efficacy, which phase is nearing (positive) completion....", Ray

Ray, this is the first I have heard reference to "long-term efficacy" being the reason for lack of FDA approval. Is this information available because I don't recall Hyrum mentioning it, or it being in any annual report.

Also is there any trial that has been completed that will followup long-term efficacy?

I like this board. Thanks for starting it.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News